CellWell record HH-166278
Dawn Phenomenon
Mansi Sharma; Abhay Sharma; Catherine Anastasopoulou
2026
In plain language
This overview describes the dawn phenomenon as early-morning hyperglycemia driven by a circadian surge in cortisol, growth hormone, catecholamines, and glucagon, affecting over half of diabetes patients.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-166278
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.